Moderna, Inc. (MRNA) Presents at Chardan 5th Annual Genetic Medicines Conference (Transcript)Seeking Alpha • 10/05/21
E.U. authorizes third dose of Moderna's COVID-19 vaccine for the immunocompromisedMarket Watch • 10/05/21
Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and OlderBusiness Wire • 10/05/21
Does the Sell-Off of BioNTech and Moderna Stocks Present a Buying Opportunity?The Motley Fool • 10/05/21
Moderna Shares Linger At 2-Month Lows: What's Next For The COVID-19 Vaccine CompanyBenzinga • 10/04/21
Moderna and BioNTech plummet more than 15% following news of Merck's COVID-19 antiviral pillBusiness Insider • 10/01/21